AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23292622 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (20-30 mg/day depending on weight)
Number of subjects: 40
Study 23292622 — intervention group
Group type: COMPARATOR
Intervention: Methylphenidate (20-30 mg/day depending on weight)
Number of subjects: 40
Study 20100371 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha‐rhamnosidase‐treated orange juice
Number of subjects: 16
Study 20100371 — intervention group
Group type: COMPARATOR
Intervention: untreated orange juice
Number of subjects: 16
Study 20100371 — intervention group
Group type: EXPERIMENTAL
Intervention: orange juice fortified with three times the original content of hesperetin‐7‐O‐rutinoside
Number of subjects: 16
Study 18756812 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozeltamivir (Tamiflu)
Number of subjects: 0
Study 15699292 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA therapy (90 mg/d for 3 weeks and 450 mg/d for 3 weeks)
Number of subjects: 46
Study 15699292 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 46
Study 15699292 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA therapy
Number of subjects: 46
Study 12022530 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonically skeletonized graft (group S)
Number of subjects: 65
Study 12022530 — intervention group
Group type: COMPARATOR
Intervention: Pedicle harvesting (group P)
Number of subjects: 65
Study 18425654 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco cessation intervention delivered by dental hygienists during cleaning visits; specific components included video and written materials; details on dosage and duration not specified.
Number of subjects: 633
Study 18425654 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group); no specific intervention details provided.
Number of subjects: 633
Study 8729141 — intervention group
Group type: COMPARATOR
Intervention: Fish Diet (FD)
Number of subjects: 1236
Study 8729141 — intervention group
Group type: COMPARATOR
Intervention: Fish Diet (FD) subgroup (n = 61)
Number of subjects: 1236
Study 8729141 — intervention group
Group type: COMPARATOR
Intervention: Fish Diet (FD) subgroup
Number of subjects: 1236
Study 8729141 — intervention group
Group type: COMPARATOR
Intervention: Vegetarian Diet (VD) subgroup (n = 55)
Number of subjects: 1236
Study 1717688 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained release formulation of tiaprofenic acid (two 300 mg capsules once a day)
Number of subjects: 119
Study 1717688 — intervention group
Group type: COMPARATOR
Intervention: Standard formulation of tiaprofenic acid (one 300 mg tablet taken twice a day)
Number of subjects: 119
Study 1717688 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 119
Study 6211228 — intervention group
Group type: EXPERIMENTAL
Intervention: aminoglutethimide-hydrocortisone
Number of subjects: 122
Study 6211228 — intervention group
Group type: COMPARATOR
Intervention: placebo aminoglutethimide-placebo hydrocortisone
Number of subjects: 122
Study 31111516 — intervention group
Group type: EXPERIMENTAL
Intervention: Online information and support programme
Number of subjects: 61
Study 27548912 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands-on training with cadaveric simulations (Group A)
Number of subjects: 30
Study 25959502 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Motivational Intervention (FMI)
Number of subjects: 75
Study 25959502 — intervention group
Group type: COMPARATOR
Intervention: Routine Family Support (RFS)
Number of subjects: 75
Study 23944194 — intervention group
Group type: EXPERIMENTAL
Intervention: Armodafinil
Number of subjects: 61
Study 23944194 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 21433021 — intervention group
Group type: EXPERIMENTAL
Intervention: VR simulator
Number of subjects: 20
Study 21433021 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching methods
Number of subjects: 20
Study 19646195 — intervention group
Group type: EXPERIMENTAL
Intervention: GlucoWatch G2 Biographer
Number of subjects: 404
Study 19646195 — intervention group
Group type: EXPERIMENTAL
Intervention: MiniMed continuous glucose monitoring system (CGMS)
Number of subjects: 404
Study 19646195 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 404
Study 19646195 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 404
Study 17917317 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan (40‐80 mg/day)
Number of subjects: 16
Study 17917317 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (20‐40 mg/day)
Number of subjects: 16
Study 17917317 — intervention group
Group type: COMPARATOR
Intervention: Control group (age- and gender-matched subjects without hypertension)
Number of subjects: 16
Study 15040652 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced pharmacist care
Number of subjects: 675
Study 15040652 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 675
Study 12536287 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum uric acid (UA) levels in MS patients
Number of subjects: 124
Study 12536287 — intervention group
Group type: COMPARATOR
Intervention: Serum uric acid (UA) levels in controls
Number of subjects: 124
Study 12536287 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of UA levels with disease activity, duration, disability, or course in MS patients
Number of subjects: 124
Study 9620489 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical agent
Number of subjects: 0
Study 9620489 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 0
Study 9620489 — intervention group
Group type: COMPARATOR
Intervention: Stripping control
Number of subjects: 0
Study 7882454 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amiodarone (600-800 mg daily) with infusional doxorubicin (60 mg/m2 over 96 h)
Number of subjects: 33
Study 7882454 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amiodarone (600-800 mg daily) with infusional vinblastine (8.5 mg/m2 over 120 h)
Number of subjects: 33
Study 7882454 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 33
Study 7882454 — intervention group
Group type: EXPERIMENTAL
Intervention: Pgp expression
Number of subjects: 33
Study 2142915 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium (80 micrograms via metered dose inhaler with each salbutamol treatment, 6 to 8 times per day)
Number of subjects: 68
Study 2142915 — intervention group
Group type: COMPARATOR
Intervention: Placebo (via metered dose inhaler with each salbutamol treatment, 6 to 8 times per day)
Number of subjects: 68
Study 2142915 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium (for patients with asthma)
Number of subjects: 68
Study 2142915 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for patients with asthma)
Number of subjects: 68
Study 2142915 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium (for patients with COPD)
Number of subjects: 68
Study 2142915 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for patients with COPD)
Number of subjects: 68
Study 599799 — intervention group
Group type: EXPERIMENTAL
Intervention: Visken (prindolol)
Number of subjects: 42
Study 599799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 31951150 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylnaltrexone
Number of subjects: 0
Study 31951150 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30316635 — intervention group
Group type: EXPERIMENTAL
Intervention: <350 mg/dL (moderate control)
Number of subjects: 110
Study 30316635 — intervention group
Group type: COMPARATOR
Intervention: <600 mg/dL (loose control)
Number of subjects: 110
Study 30316635 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat ED visits for hyperglycemia
Number of subjects: 110
Study 30316635 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitalization for hyperglycemia
Number of subjects: 110
Study 30316635 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitalization for any reason
Number of subjects: 110
Study 26364686 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐WEIGHT (low load, high repetition weight training)
Number of subjects: 20
Study 26364686 — intervention group
Group type: COMPARATOR
Intervention: S‐CORE (core focused fusion classes)
Number of subjects: 20
Study 26083474 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-Valent Pneumococcal Non-Typeable Haemophilus influenza Protein D Conjugate Vaccine (PHiD-CV)
Number of subjects: 60
Study 26083474 — intervention group
Group type: COMPARATOR
Intervention: Hepatitis A vaccine
Number of subjects: 60
Study 22985340 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who wrote about a past guilt-inducing event
Number of subjects: 0
Study 22985340 — intervention group
Group type: COMPARATOR
Intervention: Participants who wrote about feeling sad or a neutral event
Number of subjects: 0
Study 22166754 — intervention group
Group type: EXPERIMENTAL
Intervention: High PUFA diet
Number of subjects: 141
Study 22166754 — intervention group
Group type: COMPARATOR
Intervention: Low PUFA diet
Number of subjects: 141
Study 19254599 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management (SM) intervention
Number of subjects: 522
Study 16466811 — intervention group
Group type: EXPERIMENTAL
Intervention: TIVA with propofol (Group I)
Number of subjects: 25
Study 16466811 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane (Group II)
Number of subjects: 25
Study 15054015 — intervention group
Group type: COMPARATOR
Intervention: Safe Dates program
Number of subjects: 10
Study 15054015 — intervention group
Group type: EXPERIMENTAL
Intervention: Safe Dates program with booster
Number of subjects: 10
Study 11332239 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib (maximum single dose 12.5 mg, cumulative dose 25 mg)
Number of subjects: 37
Study 11332239 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 9596392 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold bath (24 degrees C) for 20 minutes
Number of subjects: 14
Study 9596392 — intervention group
Group type: COMPARATOR
Intervention: Control condition (not specified)
Number of subjects: 14
Study 7889606 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous ethanol injection after fine needle aspiration (Group 2)
Number of subjects: 52
Study 7889606 — intervention group
Group type: COMPARATOR
Intervention: Fine needle aspiration alone (Group 1)
Number of subjects: 52
Study 7889606 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous ethanol injection (Group 3)
Number of subjects: 52
Study 7889606 — intervention group
Group type: COMPARATOR
Intervention: Fluid aspiration alone (Group 1)
Number of subjects: 52
Study 7889606 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous ethanol injection (Group 2)
Number of subjects: 52
Study 3272748 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone dipropionate
Number of subjects: 30
Study 3272748 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 30690478 — intervention group
Group type: EXPERIMENTAL
Intervention: MSI identification of cryptic species
Number of subjects: 5108
Study 30690478 — intervention group
Group type: EXPERIMENTAL
Intervention: MSI identification of noncryptic species
Number of subjects: 5108
Study 26442473 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill exercise (T) at 65% VO2 R for 30 minutes
Number of subjects: 14
Study 26442473 — intervention group
Group type: COMPARATOR
Intervention: Cycle exercise (C) at 65% VO2 R for 30 minutes
Number of subjects: 14
Study 26481907 — intervention group
Group type: EXPERIMENTAL
Intervention: Active right dorsolateral prefrontal cortex (dlPFC) stimulation with rTMS (10 Hz)
Number of subjects: 38
Study 26481907 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 38
Study 23732514 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner-with-encouragement (n=55)
Number of subjects: 115
Study 23732514 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner-without-encouragement (n=25)
Number of subjects: 115
Study 23732514 — intervention group
Group type: COMPARATOR
Intervention: Individual (n=35)
Number of subjects: 115
Study 23732514 — intervention group
Group type: EXPERIMENTAL
Intervention: Online teams (n=80)
Number of subjects: 115
Study 21730079 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-step hand hygiene process (hand hygiene education plus institutionally provided alcohol-based hand sanitizer)
Number of subjects: 527
Study 21730079 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 527
Study 19593996 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-period sperm-oocyte coincubation with early rescue ICSI
Number of subjects: 115
Study 19593996 — intervention group
Group type: COMPARATOR
Intervention: Overnight fertilization
Number of subjects: 115
Study 17175328 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin
Number of subjects: 39
Study 17175328 — intervention group
Group type: COMPARATOR
Intervention: Lactulose
Number of subjects: 39
Study 12855921 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal ketoprofen applied TID to quadriceps
Number of subjects: 32
Study 12855921 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream applied TID to quadriceps
Number of subjects: 32
Study 12855921 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal ketoprofen
Number of subjects: 32
Study 10911654 — intervention group
Group type: EXPERIMENTAL
Intervention: Icodextrin (I) solution
Number of subjects: 38
Study 10911654 — intervention group
Group type: EXPERIMENTAL
Intervention: Icodextrin (I) solution during peritonitis (P)
Number of subjects: 38
Study 10911654 — intervention group
Group type: COMPARATOR
Intervention: Glucose (G) solution
Number of subjects: 38
Study 10911654 — intervention group
Group type: COMPARATOR
Intervention: Glucose (G) solution during peritonitis (P)
Number of subjects: 38
Study 8616558 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow inspiration
Number of subjects: 15
Study 8616558 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath hold
Number of subjects: 15
Study 8616558 — intervention group
Group type: COMPARATOR
Intervention: Fast inspiration
Number of subjects: 15
Study 8616558 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized bronchodilator
Number of subjects: 15
Study 8616558 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung elastic recoil pressure (Pel Blow)
Number of subjects: 15
Study 8616558 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath hold time
Number of subjects: 15
Study 1477688 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-fentanyl (P/F)
Number of subjects: 75
Study 1477688 — intervention group
Group type: COMPARATOR
Intervention: Midazolam-fentanyl (M/F)
Number of subjects: 75
Study 6088396 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh human milk (200 ml per day)
Number of subjects: 30
Study 6088396 — intervention group
Group type: COMPARATOR
Intervention: Formula diet (control group)
Number of subjects: 30
Study 31158560 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) plus standardised medical care
Number of subjects: 368
Study 31158560 — intervention group
Group type: COMPARATOR
Intervention: Standardised medical care alone
Number of subjects: 368
Study 30374788 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar spine bone mineral density (LS‐BMD)
Number of subjects: 5214
Study 30374788 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone mineral apparent density (LS‐BMAD)
Number of subjects: 5214
Study 27515301 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A
Number of subjects: 14
Study 27515301 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 14
Study 24659069 — intervention group
Group type: COMPARATOR
Intervention: Intravenous sedation (IVS) with midazolam/fentanyl
Number of subjects: 60
Study 24659069 — intervention group
Group type: EXPERIMENTAL
Intervention: Axillary nerve block (ANB)
Number of subjects: 60
Study 22207530 — intervention group
Group type: EXPERIMENTAL
Intervention: Floseal (FS)
Number of subjects: 176
Study 22207530 — intervention group
Group type: COMPARATOR
Intervention: Electrocautery (EC)
Number of subjects: 176
Study 20097931 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab 4 mg/kg
Number of subjects: 1793
Study 20097931 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab 8 mg/kg
Number of subjects: 1793
Study 20097931 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (4 or 8 mg/kg)
Number of subjects: 1793
Study 18773532 — intervention group
Group type: EXPERIMENTAL
Intervention: Cleavage stage embryos transferred on day two or three
Number of subjects: 0
Study 18773532 — intervention group
Group type: EXPERIMENTAL
Intervention: Single embryo transfer
Number of subjects: 0
Study 18773532 — intervention group
Group type: EXPERIMENTAL
Intervention: Three embryos transferred
Number of subjects: 0
Study 18773532 — intervention group
Group type: EXPERIMENTAL
Intervention: Four embryos transferred
Number of subjects: 0
Study 18773532 — intervention group
Group type: EXPERIMENTAL
Intervention: More embryos than recommended
Number of subjects: 0
Study 18773532 — intervention group
Group type: EXPERIMENTAL
Intervention: Fewer embryos transferred
Number of subjects: 0
Study 18773532 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling regarding risks of multifetal gestation
Number of subjects: 0
Study 18773532 — intervention group
Group type: EXPERIMENTAL
Intervention: Public funding strategy for IVF-ET
Number of subjects: 0
Study 18773532 — intervention group
Group type: EXPERIMENTAL
Intervention: Guidelines for cycle cancellation
Number of subjects: 0
Study 11137632 — intervention group
Group type: EXPERIMENTAL
Intervention: OptiBond Solo
Number of subjects: 33
Study 11137632 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime & Bond 2.1
Number of subjects: 33
Study 9145453 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant vitamins (A, C, and E)
Number of subjects: 209
Study 9145453 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose
Number of subjects: 209
Study 9145453 — intervention group
Group type: COMPARATOR
Intervention: No treatment (untreated controls)
Number of subjects: 209
Study 9145453 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (600 mg/day)
Number of subjects: 209
Study 9145453 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower doses of antioxidant vitamins
Number of subjects: 209
Study 7969600 — intervention group
Group type: EXPERIMENTAL
Intervention: Touching of own genitals
Number of subjects: 362
Study 7969600 — intervention group
Group type: EXPERIMENTAL
Intervention: Playing doctor
Number of subjects: 362
Study 7969600 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult-like sexual behaviour
Number of subjects: 362
Study 7969600 — intervention group
Group type: EXPERIMENTAL
Intervention: Family nudity
Number of subjects: 362
Study 7969600 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental education level
Number of subjects: 362
Study 3679735 — intervention group
Group type: EXPERIMENTAL
Intervention: Early physiotherapy
Number of subjects: 68
Study 3679735 — intervention group
Group type: COMPARATOR
Intervention: Delayed physiotherapy
Number of subjects: 68
Study 3679735 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified radical mastectomy
Number of subjects: 68
Study 3679735 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative procedure
Number of subjects: 68
Study 31895774 — intervention group
Group type: COMPARATOR
Intervention: MAC (conventional Macintosh laryngoscope without additional intubation aids)
Number of subjects: 39
Study 31895774 — intervention group
Group type: EXPERIMENTAL
Intervention: GEB (conventional Macintosh laryngoscope with gum‐elastic bougie)
Number of subjects: 39
Study 31895774 — intervention group
Group type: EXPERIMENTAL
Intervention: FTB (flexible tip bougie)
Number of subjects: 39
Study 31895774 — intervention group
Group type: EXPERIMENTAL
Intervention: GEB
Number of subjects: 39
Study 31895774 — intervention group
Group type: EXPERIMENTAL
Intervention: FTB
Number of subjects: 39
Study 31895774 — intervention group
Group type: COMPARATOR
Intervention: MAC
Number of subjects: 39
Study 31138171 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-Led physical Activity intervention (PLAN-A)
Number of subjects: 20
Study 31138171 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study 31138171 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report psychosocial questionnaire
Number of subjects: 20
Study 31138171 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic evaluation measures
Number of subjects: 20
Study 31138171 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-methods process evaluation
Number of subjects: 20
Study 28410972 — intervention group
Group type: EXPERIMENTAL
Intervention: Authentic Connections Groups (n = 21)
Number of subjects: 40
Study 28410972 — intervention group
Group type: COMPARATOR
Intervention: Control condition (n = 19)
Number of subjects: 40
Study 26176848 — intervention group
Group type: EXPERIMENTAL
Intervention: EC-MPS
Number of subjects: 101
Study 26176848 — intervention group
Group type: COMPARATOR
Intervention: MMF
Number of subjects: 101
Study 23278851 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclopirox lacquer
Number of subjects: 40
Study 23278851 — intervention group
Group type: COMPARATOR
Intervention: Vehicle lacquer
Number of subjects: 40
Study 21526411 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacy First Minor Ailments scheme
Number of subjects: 0
Study 18059393 — intervention group
Group type: EXPERIMENTAL
Intervention: Total antibiotic use
Number of subjects: 1348
Study 18059393 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic use by site
Number of subjects: 1348
Study 18059393 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency of antibiotic use
Number of subjects: 1348
Study 18059393 — intervention group
Group type: EXPERIMENTAL
Intervention: Age at first antibiotic use
Number of subjects: 1348
Study 17044452 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal vaccination (ID group) - 10 microg of recombinant hepatitis B vaccine (Engerix B) intradermally every 2 weeks for a total of 7 doses.
Number of subjects: 51
Study 17044452 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular vaccination (IM group) - 40 microg intramuscularly at 0, 1, 2, and 6 months.
Number of subjects: 51
Study 17044452 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal vaccination (ID group)
Number of subjects: 51